- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Correlative studies offer ample data on CTA's value in coronaries
"While the literature specific to coronary CT angiography is not as robust as it could be, there are plenty of correlative studies. We have a huge body of data looking at coronary catheter angiograms. If a coronary cath is normal, the prognosis is quite good. In many respects, the CTA is better than the standard invasive angiogram. I think we want to make the leap of faith that a normal is a normal no matter which way you do it. The prognostic value is as good for coronary CTA in a well-done study on a quality machine as it is for catheter angiography.
"The problem is that payers will resist reimbursing for CTA until clinical outcome data are there. That will take years. In the meantime, patients get caught in a revolving door of nuclear tests and/or invasive angiography when a negative CT would obviate the need for any other test."
-Dr. Michael L. Ridner, a cardiologist with The Heart Center in Huntsville, AL, in an interview with Diagnostic Imaging.
AI Mammography Platform Shows Promising Results for Detecting Subclinical Breast Cancer
October 3rd 2024Mean artificial intelligence (AI) scoring for breasts developing cancer was double that of contralateral breasts at initial biennial screening and was 16 times higher at the third biennial screening, according to a study involving over 116,000 women with no prior history of breast cancer.
FDA Clears Software for Enhancing CCTA Assessment of Atherosclerosis
October 1st 2024Through analysis of coronary computed tomography angiography (CCTA) images, the PlaqueIQ software provides quantification and classification of atherosclerosis, a common cause of myocardial infarction (MI) and ischemic stroke.
